A big study yields big questions.
Zuger
Abigail
A
St. Luke's-Roosevelt Hospital Center, New York, USA.
D058891:5-alpha Reductase Inhibitors; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D018120:Finasteride / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000517:prevention & control*; D012306:Risk
D058891:5-alpha Reductase Inhibitors; D018931:Antineoplastic Agents, Hormonal; D018120:Finasteride; D017430:Prostate-Specific Antigen